NOD2 Agonism Counter-Regulates Human Type 2 T Cell Functions in Peripheral Blood Mononuclear Cell Cultures: Implications for Atopic Dermatitis

By sjmartinez • February 26, 2023

Gimenez-Rivera VA, Patel H, Dupuy FP, Allakhverdi Z, Bouchard C, Madrenas J, Bissonnette R, Piccirillo CA, Jack C. NOD2 Agonism Counter-Regulates Human Type 2 T Cell Functions in Peripheral Blood Mononuclear Cell Cultures: Implications for Atopic Dermatitis. Biomolecules. 2023 Feb 15;13(2):369. doi: 10.3390/biom13020369. PMID: 36830738; PMCID: PMC9953199.

Tags: atopic dermatitis, GATA Binding Protein 3, General Internal Medicine, interleukin-13, nucleotide-binding oligomerization domain-containing protein 2, peptidoglycan, Publications, signal transducer of activated T cells, Staphylococcus aureus, Staphylococcus aureus enterotoxin B, T helper 2 and cytotoxic type 2 T cells, thymic stromal lymphopoietin, thymus and activation-related chemokine, type 2 cytokines

William J. Carroll, MD, FACP Appointed Section Chief of Palliative Care and Extensivist Medicine

The UCLA Department of Medicine (DoM) is pleased to announce the appointment of William J. Carroll, MD, FACPas section chief of the UCLA DoM Palliative Care[...]

Joshua N. Khalili, MD Appointed to DoM Chief Wellness Officer

The UCLA Department of Medicine has appointed Joshua N. Khalili, MD to chief wellness officer (CWO) effective April 1. The appointment builds on Dr. Khalili’s outstanding work[...]

Sun M. Yoo, MD, MPH to Depart DoM to Pursue New Leadership Opportunity

The UCLA Department of Medicine (DoM) announces that Sun M. Yoo, MD, MPH, will be departing UCLA Health to assume the role of a founding chief[...]